Absolute Configuration of Isosilybin A by X-ray Crystallography of the Heavy Atom Analogue 7-(4-Bromobenzoyl)isosilybin A
- 1 November 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 75 (11) , 1879-1881
Abstract
Isosilybin A (1) is one of the major flavonolignans that constitute silymarin, an extract of the fruits (achenes) of milk thistle (Silybum marianum). The chemistry of the Silybum flavonolignans has been studied for over four decades, and the absolute configuration of 1 has been determined previously by electronic circular dichroism and X-ray crystallography via correlating the relative configuration of the phenylpropanoid moiety to the established absolute configuration of the 3-hydroxyflavanone portion of the molecule. Herein we report the X-ray crystallographic structure of the product of the reaction of 1 with 4-bromobenzoyl chloride, and, thus, the absolute configuration of 1 was established as (2R, 3R, 7″R, 8″R) directly via X-ray crystallography of an analogue that incorporated a heavy atom. The results were consistent with previously reported assignments and verified the absolute configuration of the diastereoisomer of 1, isosilybin B, and the related diastereoisomeric regioisomers, silybin A and silybin B.Keywords
This publication has 36 references indexed in Scilit:
- Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR SignalingPLOS ONE, 2012
- Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and InflammationPLOS ONE, 2011
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancerCancer and Metastasis Reviews, 2010
- Multiple Effects of Silymarin on the Hepatitis C Virus LifecycleHepatology, 2010
- Identification of hepatoprotective flavonolignans from silymarinProceedings of the National Academy of Sciences, 2010
- Two Flavonolignans from Milk Thistle (Silybum marianum) Inhibit CYP2C9-Mediated Warfarin Metabolism at Clinically Achievable ConcentrationsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus InfectionGastroenterology, 2010
- Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective propertiesBioorganic & Medicinal Chemistry, 2009
- Multitargeted therapy of cancer by silymarinCancer Letters, 2008
- Total synthesis of (.+-.)-silybin, an antihepatotoxic flavonolignan.Chemical and Pharmaceutical Bulletin, 1985